We classified pathological stages of endometrial cancer patients according to FIGO criteria and found CD47 mRNA expression levels were higher in the stage III-IV groups (Figure 1B), further suggesting a correlation between CD47 mRNA expression levels and endometrial carcinoma progression. The gene discussed is CD47; the disease is endometrial cancer.